Alida Biosciences Secures Series A Funding
Exciting News for Epigenomic Research
Alida Biosciences, a leader in epigenomic research tools, is thrilled to announce the successful closing of a $7.5 million Series A funding round. This round was led by Genoa Ventures, along with FusionX Ventures and Vertical Venture Partners. In addition to this funding, AlidaBio has secured two ongoing SBIR grants totaling $4 million from The National Human Genome Research Institute.
Furthermore, AlidaBio is excited to introduce the Early Access launch of two groundbreaking products: the EpiPlex™ RNA Library Prep Kit and the EpiScout™ Analysis Suite. These products offer a comprehensive solution for multiplexed epitranscriptomic analysis of clinical research RNA samples with limited input, providing unmatched sensitivity and accuracy.
More Information : https://www.techdogs.com/tech-news/pr-newswire/alida-biosciences-announces-series-a-funding-and-early-access-launch-of-innovative-products-for-epitranscriptomic-research
Comments
Post a Comment